Logo image of LAWS

LAWSON PRODUCTS INC (LAWS) Stock Fundamental Analysis

NASDAQ:LAWS - Nasdaq - US5207761058 - Common Stock

40.42  -0.73 (-1.77%)

After market: 40.42 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LAWS. LAWS was compared to 48 industry peers in the Trading Companies & Distributors industry. LAWS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, LAWS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

LAWS had positive earnings in the past year.
LAWS Yearly Net Income VS EBIT VS OCF VS FCFLAWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M 20M 30M

1.2 Ratios

Industry RankSector Rank
ROA 5.47%
ROE 10.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LAWS Yearly ROA, ROE, ROICLAWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 20 30

1.3 Margins

Industry RankSector Rank
OM 5.15%
PM (TTM) 3.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LAWS Yearly Profit, Operating, Gross MarginsLAWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

3

2. Health

2.1 Basic Checks

LAWS has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for LAWS is higher compared to a year ago.
LAWS Yearly Shares OutstandingLAWS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M
LAWS Yearly Total Debt VS Total AssetsLAWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

LAWS has an Altman-Z score of 6.47. This indicates that LAWS is financially healthy and has little risk of bankruptcy at the moment.
LAWS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 6.47
ROIC/WACCN/A
WACCN/A
LAWS Yearly LT Debt VS Equity VS FCFLAWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 2.05 indicates that LAWS has no problem at all paying its short term obligations.
A Quick Ratio of 0.97 indicates that LAWS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 0.97
LAWS Yearly Current Assets VS Current LiabilitesLAWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M

6

3. Growth

3.1 Past

LAWS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.87%, which is quite impressive.
The Earnings Per Share has been growing by 153.17% on average over the past years. This is a very strong growth
Looking at the last year, LAWS shows a quite strong growth in Revenue. The Revenue has grown by 18.66% in the last year.
Measured over the past years, LAWS shows a quite strong growth in Revenue. The Revenue has been growing by 8.59% on average per year.
EPS 1Y (TTM)152.87%
EPS 3Y16.37%
EPS 5Y153.17%
EPS Q2Q%26.67%
Revenue 1Y (TTM)18.66%
Revenue growth 3Y6.11%
Revenue growth 5Y8.59%
Sales Q2Q%13.78%

3.2 Future

The Earnings Per Share is expected to grow by 15.95% on average over the next years. This is quite good.
Based on estimates for the next years, LAWS will show a small growth in Revenue. The Revenue will grow by 4.99% on average per year.
EPS Next Y23.33%
EPS Next 2Y19.87%
EPS Next 3Y16.86%
EPS Next 5Y15.95%
Revenue Next Year6.61%
Revenue Next 2Y5.51%
Revenue Next 3Y4.81%
Revenue Next 5Y4.99%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LAWS Yearly Revenue VS EstimatesLAWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
LAWS Yearly EPS VS EstimatesLAWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.37, LAWS is valued on the expensive side.
When comparing the Price/Earnings ratio of LAWS to the average of the S&P500 Index (27.24), we can say LAWS is valued slightly cheaper.
With a Price/Forward Earnings ratio of 13.52, LAWS is valued correctly.
The average S&P500 Price/Forward Earnings ratio is at 36.42. LAWS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.37
Fwd PE 13.52
LAWS Price Earnings VS Forward Price EarningsLAWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.87
LAWS Per share dataLAWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LAWS's earnings are expected to grow with 16.86% in the coming years.
PEG (NY)0.79
PEG (5Y)0.12
EPS Next 2Y19.87%
EPS Next 3Y16.86%

0

5. Dividend

5.1 Amount

LAWS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LAWSON PRODUCTS INC

NASDAQ:LAWS (5/6/2022, 8:00:03 PM)

After market: 40.42 0 (0%)

40.42

-0.73 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-28 2022-04-28/bmo
Earnings (Next)07-27 2022-07-27
Inst Owners223.21%
Inst Owner Change0.34%
Ins Owners63.31%
Ins Owner Change0%
Market Cap784.96M
Analysts82.5
Price Target62.22 (53.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.37
Fwd PE 13.52
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 5.5
P/tB N/A
EV/EBITDA 25.87
EPS(TTM)2.2
EY5.44%
EPS(NY)2.99
Fwd EY7.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS22.25
BVpS7.35
TBVpSN/A
PEG (NY)0.79
PEG (5Y)0.12
Profitability
Industry RankSector Rank
ROA 5.47%
ROE 10.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.15%
PM (TTM) 3.42%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 0.97
Altman-Z 6.47
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.87%
EPS 3Y16.37%
EPS 5Y153.17%
EPS Q2Q%26.67%
EPS Next Y23.33%
EPS Next 2Y19.87%
EPS Next 3Y16.86%
EPS Next 5Y15.95%
Revenue 1Y (TTM)18.66%
Revenue growth 3Y6.11%
Revenue growth 5Y8.59%
Sales Q2Q%13.78%
Revenue Next Year6.61%
Revenue Next 2Y5.51%
Revenue Next 3Y4.81%
Revenue Next 5Y4.99%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A